Are there predictive factors for a pathological complete response after neoadjuvant chemotherapy in locally advanced breast cancer?

被引：0
|
作者：
Warm, M.
Cramer, E-M
Bosse, K.
Moers, C.
Thomas, A.
Mallmann, P.
机构：
[1] Univ Hosp, Cologne, Germany
[2] Univ Med Berlin, Campus Charite Mitte, Berlin, Germany
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S154 / S154
页数：1
相关论文
共 50 条
  • [31] Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
    Fernández-Sánchez, M
    Gamboa-Dominguez, A
    Uribe, N
    García-Ulloa, AC
    Flores-Estrada, D
    Candelaria, M
    Arrieta, O
    [J]. MEDICAL ONCOLOGY, 2006, 23 (02) : 171 - 183
  • [32] Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
    Mónica Fernández-Sánchez
    Armando Gamboa-Dominguez
    Norma Uribe
    Ana Cristina García-Ulloa
    Diana Flores-Estrada
    Myrna Candelaria
    Oscar Arrieta
    [J]. Medical Oncology, 2006, 23 : 171 - 183
  • [33] Can mammographic breast density predict complete pathological response in patients with locally advanced breast cancer following neoadjuvant chemotherapy?
    Agarwal, Veenoo
    Spalding, Lisa
    Blick, Tony
    Thompson, Erik W.
    Dobrovic, Alexander
    Redfern, Andrew
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 65 - 65
  • [34] Analyses of predictive factors for pathological complete remission in neoadjuvant therapy for locally advanced rectal cancer
    Yang, Jun
    Ling, Xin
    Tang, Wen
    Hu, Duanmin
    Zhou, Haiyun
    Yin, Guojian
    [J]. JOURNAL OF BUON, 2019, 24 (01): : 77 - 83
  • [35] Improving pathological complete response in luminal breast cancer after neoadjuvant chemotherapy
    Cudos, Ariadna Gasol
    Murillo, Serafin Morales
    Galindo, Alvaro Rodriguez
    Subirats, Ona Pallise
    Olive, Jordi Mele
    Morales, Carles Canosa
    Villellas, Felip Vilardell
    Guzman, Douglas Rene Sanchez
    Rodriguez, Joel Veas
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [36] Demographic determinants of pathological complete response after neoadjuvant chemotherapy in breast cancer
    Dharanikota, A.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1482 - S1482
  • [37] Characteristics of breast cancer patients with pathological complete response after neoadjuvant chemotherapy
    Kolacinska, Agnieszka
    Blasinska-Morawiec, Maria
    Dowgier-Witczak, Izabela
    Kordek, Radzislaw
    Morawiec, Zbigniew
    [J]. MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2010, 9 (05): : 300 - 304
  • [38] Pathological complete response (pCR) after neoadjuvant chemotherapy in luminal breast cancer
    Cordoba Ortega, J. F.
    Gasol Cudos, A.
    Morales Murillo, S.
    Vilardell Villellas, F.
    Siso Raber, C.
    Canosa Morales, C.
    Salud Salvia, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S313 - S313
  • [39] Predictive factors of distant recurrence disease in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy
    Ponce, J.
    Rodriguez-Lescure, A.
    Delgado, S.
    Peiro, G.
    Pastor-Valero, M.
    Reche, M.
    Lozano, I.
    Massuti Sureda, B.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S341 - S342
  • [40] CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
    Wilson Eduardo Furlan Matos Alves
    Murilo Bonatelli
    Rozany Dufloth
    Lígia Maria Kerr
    Guilherme Freire Angotti Carrara
    Ricardo Filipe Alves da Costa
    Cristovam Scapulatempo-Neto
    Daniel Tiezzi
    René Aloísio da Costa Vieira
    Céline Pinheiro
    [J]. BMC Cancer, 19
12345